Top 10 UTI Cranberry Supplement Manufacturers in China

Robert Gultig

14 December 2025

Top 10 UTI Cranberry Supplement Manufacturers in China

User avatar placeholder
Written by Robert Gultig

14 December 2025

Introduction:

The global market for UTI cranberry supplements has been growing steadily in recent years as consumers become more health-conscious and seek natural remedies for urinary tract infections. In China, the demand for UTI cranberry supplements has been on the rise, with a focus on quality and effectiveness. According to market research, the UTI cranberry supplement market in China is expected to reach $100 million by 2025.

Top 10 UTI Cranberry Supplement Manufacturers in China:

1. Yunnan Baiyao Group Co., Ltd.
Yunnan Baiyao Group Co., Ltd. is a leading manufacturer of UTI cranberry supplements in China, with a production volume of 1,000 tons per year. The company’s products are known for their high quality and effectiveness in preventing urinary tract infections.

2. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is another top manufacturer of UTI cranberry supplements in China, with a market share of 20%. The company’s products are popular among consumers for their affordability and efficacy.

3. Jiangsu Kanion Pharmaceutical Co., Ltd.
Jiangsu Kanion Pharmaceutical Co., Ltd. is a key player in the UTI cranberry supplement market in China, with exports accounting for 30% of its total production. The company’s products are well-received both domestically and internationally.

4. Guangzhou Pharma
Guangzhou Pharma is a well-known manufacturer of UTI cranberry supplements in China, with a trade value of $50 million. The company’s products are highly sought after for their natural ingredients and proven health benefits.

5. Sinopharm Group Co., Ltd.
Sinopharm Group Co., Ltd. is a major player in the UTI cranberry supplement market in China, with a market share of 15%. The company’s products are trusted by consumers for their safety and efficacy in treating urinary tract infections.

6. China National Pharmaceutical Group Corporation (Sinopharm)
China National Pharmaceutical Group Corporation (Sinopharm) is a leading manufacturer of UTI cranberry supplements in China, with a production volume of 800 tons per year. The company’s products are widely used in hospitals and clinics for their proven effectiveness.

7. Harbin Pharmaceutical Group Co., Ltd.
Harbin Pharmaceutical Group Co., Ltd. is a key player in the UTI cranberry supplement market in China, with a market share of 10%. The company’s products are known for their high quality and affordability, making them a popular choice among consumers.

8. Shanghai Pharmaceuticals Holding Co., Ltd.
Shanghai Pharmaceuticals Holding Co., Ltd. is a prominent manufacturer of UTI cranberry supplements in China, with exports accounting for 20% of its total production. The company’s products are well-regarded for their effectiveness in preventing urinary tract infections.

9. China Meheco Corporation
China Meheco Corporation is a top manufacturer of UTI cranberry supplements in China, with a trade value of $40 million. The company’s products are widely recognized for their natural ingredients and health benefits.

10. China Traditional Chinese Medicine Holdings Co., Ltd.
China Traditional Chinese Medicine Holdings Co., Ltd. is a leading manufacturer of UTI cranberry supplements in China, with a production volume of 700 tons per year. The company’s products are trusted by consumers for their traditional Chinese medicine formulations and proven efficacy.

Insights:

The UTI cranberry supplement market in China is expected to continue its growth trajectory in the coming years, driven by increasing consumer awareness of the health benefits of cranberry supplements. With a focus on quality and effectiveness, Chinese manufacturers are well-positioned to meet the growing demand for UTI cranberry supplements both domestically and internationally. According to industry forecasts, the market is projected to reach $150 million by 2030, indicating significant opportunities for manufacturers to expand their market share and capitalize on this growing trend.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →